...
首页> 外文期刊>The Journal of molecular diagnostics: JMD >Somatic Mutation Screening Using Archival Formalin-Fixed, Paraffin-Embedded Tissues by Fluidigm Multiplex PCR and Illumina Sequencing
【24h】

Somatic Mutation Screening Using Archival Formalin-Fixed, Paraffin-Embedded Tissues by Fluidigm Multiplex PCR and Illumina Sequencing

机译:使用Fluidigm多重PCR和Illumina测序技术使用档案福尔马林固定,石蜡包埋的组织进行体细胞突变筛选

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

High-throughput somatic mutation screening using FFPE tissues is a major challenge because of a Lack of established methods and validated variant calling algorithms. We aimed to develop a targeted sequencing protocol by Fluidigm multiplex PCR and Illumina sequencing and to establish a companion variant calling algorithm. The experimental protocol and variant calling algorithm were first developed and optimized against a series of somatic mutations (147 substitutions, 12 indels ranging from 1 to 33 bp) in seven genes, previously detected by Sanger sequencing of DNA from 163 FFPE lymphoma biopsy specimens. The optimized experimental protocol and variant calling algorithm were further ascertained in two separate experiments by including the seven genes as a part of Larger gene panels (22 or 13 genes) using FFPE and high-molecular-weight lymphoma DNAs, respectively. We found that most false-positive variants were due to DNA degradation, deamination, and Taq polymerase errors, but they were nonreproducible and could be efficiently eliminated by duplicate experiments. A small fraction of false-positive variants appeared in duplicate, but they were at low alternative allele frequencies and could be separated from mutations when appropriate threshold value was used. In conclusion, we established a robust practical approach for high-throughput mutation screening using archival FFPE tissues.
机译:由于缺乏成熟的方法和经过验证的变异调用算法,使用FFPE组织进行高通量的体细胞突变筛查是一项重大挑战。我们旨在通过Fluidigm多重PCR和Illumina测序开发有针对性的测序方案,并建立伴随变异调用算法。实验方案和变异调用算法首先针对七个基因中的一系列体细胞突变(147个置换,12个插入缺失,范围从1到33 bp)进行了开发和优化,之前已通过Sanger对163个FFPE淋巴瘤活检样本的DNA进行了测序。通过分别使用FFPE和高分子量淋巴瘤DNA将这七个基因作为更大基因面板(22个或13个基因)的一部分,在两个单独的实验中进一步确定了优化的实验方案和变异调用算法。我们发现大多数假阳性变异是由于DNA降解,脱氨和Taq聚合酶错误引起的,但它们是不可复制的,可以通过重复实验有效地消除。一小部分假阳性变异体一式两份出现,但是它们的等位基因替代频率很低,当使用适当的阈值时可以与突变分离。总之,我们建立了使用档案FFPE组织进行高通量突变筛选的可靠实用方法。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号